-
PRMT5, Splicing, and Metabolism in MYCN Neuroblastoma
2026-09-04
This Cancer Letters study shows that MYCN-amplified neuroblastoma depends on PRMT5-mediated control of RNA splicing, epitranscriptomic regulation, and glutamine metabolism. Its integrated transcriptomic, metabolic, molecular, and in vivo analyses identify GLS regulation as a mechanistic consequence of spliceosomal stress rather than an isolated metabolic phenotype.
-
Vasopressin Analogues: Innovation and Evidence
2026-09-04
Glavaš and colleagues review how vasopressin structure, receptor pharmacology, and peptide engineering have produced analogues with more selective antidiuretic, vasoconstrictive, or longer-acting profiles. The article is especially useful for interpreting lypressin, desmopressin, and terlipressin as distinct pharmacological tools while identifying the translational limits of peptide delivery and emerging antiviral hypotheses.
-
7-Ethyl-10-hydroxycamptothecin Research Workflows
2026-09-03
Build more informative cancer assays with 7-Ethyl-10-hydroxycamptothecin (SN-38), combining topoisomerase I stress, apoptosis, cell-cycle profiling, and FUBP1/FUSE readouts. This practical guide covers solvent handling, time-course design, metastatic colon cancer models, and troubleshooting for advanced oncology research.
-
Oltipraz: A Redox Lens on MASLD Assays
2026-09-03
Oltipraz offers a defined small-molecule framework for studying Nrf2-linked detoxification, oxidative stress, autophagy, and ferroptosis in MASLD research. This assay-centered guide explains how to connect phase II enzyme induction with the mechanistic findings of a recent QSHXO study without overstating translational evidence.
-
CB-839: A Mechanistic Probe of GLS1 Dependence
2026-09-02
CB-839 (Telaglenastat) provides a direct, reversible way to test GLS1 dependence in cancer metabolism research. This article connects PRMT5-linked glutamine disruption in MYCN-amplified neuroblastoma with practical assay decisions without conflating upstream splicing effects with direct glutaminolysis inhibition.
-
Cy3-UTP Workflow for RNA Nanoparticle Tracking
2026-09-02
Cy3-UTP enables direct, bright RNA labeling for in vitro transcription, particle tracking, RNA-protein interaction studies, and quantitative detection. This workflow translates nanoparticle structure-function findings into practical fluorescence controls while addressing labeling density, photostability, storage, and assay interpretation.
-
CB-839 (Telaglenastat) for Glutamine Metabolism
2026-09-01
CB-839 (Telaglenastat) provides a selective, reversible way to test whether GLS1-dependent glutaminolysis supports tumor growth, apoptosis, or autophagy. This workflow-focused guide connects metabolic assays with the PRMT5–splicing findings in MYCN-amplified neuroblastoma while preserving the distinction between published evidence and practical assay recommendations.
-
Tamoxifen in MCF-7 Assay Interpretation
2026-09-01
Tamoxifen is more than a selective estrogen receptor modulator in MCF-7 experiments. This guide explains how to interpret its effects on viability, migration, colony formation, and caveolin-1 while designing stronger mechanistic controls.
-
CB-839 (Telaglenastat) in Cancer Metabolism
2026-08-31
Build a robust CB-839 workflow that connects GLS1 inhibition with glutamine tracing, apoptosis, and autophagy measurements. The approach extends recent MYCN-neuroblastoma findings into practical cancer metabolism research and preclinical drug evaluation without treating upstream PRMT5 biology as a substitute for direct GLS1 inhibition.
-
Bradykinin (BA5201): Practical Workflow Guide
2026-08-31
This guide explains how to handle Bradykinin (BA5201) for controlled studies of vascular reactivity, permeability, smooth muscle responses, pain mechanisms, and inflammation signaling. It covers product-specific storage and handling requirements while distinguishing them from workflow recommendations; it is not a clinical, diagnostic, or medical-use protocol.
-
Puerarin Activates NO Signaling in Dental Follicle Cells
2026-08-30
The reference study shows that puerarin enhances osteogenic differentiation of rat dental follicle cells and links this response to nitric oxide–cGMP signaling. Its inhibitor-based design provides a useful framework for testing pathway involvement in periodontal regeneration research while highlighting the limits of cell-culture evidence.
-
4-Phenylbutyric Acid: A Causal ER Stress Tool
2026-08-29
Explore how 4-Phenylbutyric acid and 4-PBA can distinguish endoplasmic reticulum stress from downstream ferroptosis, apoptosis, and autophagy. This article presents a causal assay framework grounded in a PFOS-exposed kidney-cell study and practical reagent considerations.
-
CB-839 (Telaglenastat): Reliable Assays
2026-08-28
Learn how CB-839 (Telaglenastat), SKU B4799, can improve the design and interpretation of glutaminolysis inhibition assays in cancer metabolism research. This scenario-based guide connects GLS1 biology, practical compound handling, viability readouts, and splicing-linked metabolic vulnerability.
-
VX-765 Workflow for Caspase-1 and Pyroptosis Studies
2026-08-28
VX-765 enables selective interrogation of caspase-1-driven cytokine release and pyroptotic death rather than broad inflammatory suppression. This workflow combines cytokine profiling, viability measurements, and time-resolved death analysis to improve macrophage, rheumatoid arthritis, and infectious-disease experiments.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-08-27
Oh et al. developed a scalable method for differentiating human induced pluripotent stem cells into functional sensory neurons and used the cells to reproduce key features of HSV-1 latency and reactivation. The model provides a human neuronal platform for studying viral chromatin regulation, neuron-intrinsic latency mechanisms, and candidate interventions against persistent infection.